longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Omada Health

OMDA

20.4500.10% ( +0.020 )
Trading: Sep 21, 11:13:45 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Omada Health (OMDA)

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabo...

Open
20.440
High
20.660
Low
20.280
Prev. Close
20.430
Volume
155.96K
Turnover
3.19M
Avg Price
20.470
Bid/Ask Ratio
95.35%
Amplitude
1.86%
52wk High
26.915
Volume Ratio
0.41
Turnover Ratio
0.31%
52wk Low
10.280
Float Mkt Cap
1.04B
Market CapUSD
1.25B
P/ETTM
290.80
P/EDynamic
269.34
P/EStatic
--
EPSTTM
0.0703
EPSDynamic
0.0759
EPSStatic
--
BVPS
4.13
P/B
4.95
Circulating Supply
50.86M
Dividend YieldTTM
--
DividendTTM
--
Shares
61.22M
Min lot size
1
Currency
USD

Omada Health Analyst Rating

View more

Forecast & Rating

Sep 14, 2026
Price forecast
$28.4238.96%
Forecast & RatingBuy
12analysts
  • Strong buy41.67%
  • Buy41.67%
  • Hold16.67%
  • Sell0.00%
  • Strong sell0.00%
Strong buy
5
Buy
5
Hold
2
Sell
0
Strong sell
0

News

  • PUBT · Sep 17 at 01:41 PM

    Omda names Silvija Seres to board of directors

  • Global Report · Sep 15 at 09:18 AM

    US Market's Fringe Tech and Infrastructure Plays Navigate Cross-Border Complexities

  • PUBT · Sep 11 at 08:46 PM

    Omada Health Chief Accounting Officer Craig Gracey disposes of 644 common shares worth $13,993.15

  • Market Beat · Sep 11 at 04:22 PM

    Omada Health (NASDAQ:OMDA) Trading Down 7.1% - Here's What Happened

  • Tip Ranks · Sep 11 at 09:16 AM

    Barclays Reaffirms Their Buy Rating on Omada Health, Inc. (OMDA)

  • PUBT · Sep 10 at 01:05 PM

    Omada Health targets at least 20% annual revenue growth, 30% adjusted EBITDA margin long term